Ring Energy, Inc. (NYSE:REI) last session’s volume of 0.84 million shares was higher than its average volume of 0.46 million shares. The stock, after opening at $11.8, hit $12.28 through the close by scoring 4.07%.

Ring Energy, Inc. (REI) Analyst Opinion

Ring Energy, Inc. has a consensus outperform rating from 10 Wall Street analysts, and the number of shares currently sold short amount to at least 11.6% of shares outstanding. The stock sank -2.85% last month and is down -5.47 this year. Wall Street is only getting more bullish on the stock, with 10 of analysts who cover REI having a buy-equivalent rating. Analysts have placed a $18.7 price target on Ring Energy, Inc., suggesting a 52.28% gain from recent close. It’s currently trading about -13.15% below its 52-week high.

Ring Energy, Inc. Earnings Surprise

Ring Energy, Inc. (REI) failed to surprise the stock market in its last reported earnings when it earned $0.03 a piece versus the consensus-estimated $0.03. Its revenue totaled $11.8 million up 20.04% from the previous quarter.

Ring Energy, Inc. (NYSE:REI) Intraday View

This stock (REI) is ahead of its 52-week low with 64.17%. Its last month’s stock price volatility remained 5.7% which for the week stands at 4.65%. The share price has moved backward from its 20 days moving average, trading at a distance of -6.22% and stays -2.56% away from its 50 days moving average. Over the last five days, shares have faced -6.69% losses and now is up 3.62% since hitting its 200-day moving average of $12.34. Ring Energy, Inc. (REI) has made its way to a 12-month gain of 44.98%.

Turning to CorMedix, Inc. (NYSE:CRMD), its shares were trading at $0.43 a retreat of $-0.04, on the trading floor. The stock, after opening at $0.46, touched a high of $0.47 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.5. CorMedix, Inc. has 0 buy ratings, 1 holds and 0 sells even after the stock tumbled -86.81% from its high of $3.26 to a $27.6 million market value through last close.

CorMedix, Inc. (CRMD) Consensus Price Target

The company’s consensus rating on Reuter’s scale remained unchanged from 2.5 to 2.5 during a month. Analysts set a 12-month price target of $3.5 a share. The target implies a 713.95% spike from where the shares are currently trading. Also, the current price highlights a discount of 1062.79% to analysts’ high consensus price target.

CorMedix, Inc. (NYSE:CRMD) Intraday Trading

The counter witnessed a trading volume of 0.17 million shares versus an average volume of 0.41 million shares during last trading session. Its last month’s stock price volatility remained 10.47% which for the week approaches 12.36%. The lowest price the stock reached in the last trading day was $0.43 and compares with the $0.36 52-week low. The stock recovered 19.44% since its low point and has performed -71.9% year-to-date.

Previous articleTechnical Roundup On Two Stocks – Protalix BioTherapeutics, Inc. (PLX), Glowpoint, Inc. (GLOW)
Next articleAnalyst Recommendations And Earnings Forecast: AXT, Inc. (AXTI), Ritter Pharmaceuticals, Inc. (RTTR)